BEDMINSTER, N.J. and DUBLIN, Ireland, March 6, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Amarin management is scheduled to present a corporate overview and general corporate update at the 24th Annual ROTH OC Growth Stock Conference on Monday, March 12, 2012, at 10:00 a.m. PDT. This conference will be held at the Ritz-Carlton, Laguna Niguel in Dana Point, C.A. A live audio webcast of the presentation will be available at:
